Beacon Pointe Advisors »

SPDR S&P Pharmaceuticals shares owned by Beacon Pointe Advisors

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Beacon Pointe Advisors from 13F filings

Historical chart of Beacon Pointe Advisors investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Beacon Pointe Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $211k 4.9k 42.99
2022-06-30 $202k 4.8k 41.93
2022-03-31 $210k 4.6k 45.22
2021-03-31 $213k 4.2k 50.35

More positions owned by Beacon Pointe Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Lennox International (LII)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Mid Cap Etf (VO)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)

View all positions for Beacon Pointe Advisors

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals